By Freya Barnes Published: 01:30 BST, 30 July 2024 | Updated: 01:54 BST, 30 July 2024 A life-extending drug for incurable breast cancer will not be made available through the NHS because of the cost. Campaigners reacted with outrage to the decision on trastuzumab deruxtecan, sold under the brand name Enhertu, saying it deprives patients […]

Life-extending drug for incurable breast cancer WILL NOT be made available by the NHS amid row over costs